Edgewise Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.

About EWTX

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.

CEO

Kevin Koch

CEOKevin Koch

Employees

110

Employees110

Headquarters

Boulder, Colorado

HeadquartersBoulder, Colorado

Founded

2017

Founded2017

Employees

110

Employees110

EWTX Key Statistics

Market cap

1.56B

Market cap1.56B

Price-Earnings ratio

-9.55

Price-Earnings ratio-9.55

Dividend yield

—

Dividend yield—

Average volume

619.79K

Average volume619.79K

High today

$15.18

High today$15.18

Low today

$14.58

Low today$14.58

Open price

$14.73

Open price$14.73

Volume

550.97K

Volume550.97K

52 Week high

$38.12

52 Week high$38.12

52 Week low

$10.60

52 Week low$10.60

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own EWTX. This list is generated using Robinhood data, and it’s not a recommendation.